<DOC>
	<DOCNO>NCT01214837</DOCNO>
	<brief_summary>The purpose study assess immunogenicity 3-dose versus 4-dose infant vaccination schedule include kinetics immune response early phase series .</brief_summary>
	<brief_title>Safety Immunogenicity 2 3 Doses MenACWY Conjugate Vaccine Healthy Infants Effects Booster Dose MenACWY Administered Second Year Life</brief_title>
	<detailed_description />
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningococcal Infections</mesh_term>
	<mesh_term>Meningitis , Meningococcal</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infants gender generally good health eligible study . For infant enrol , parents/legal representative need provide write informed consent available study visit . Serious , acute , chronic illness reason exclusion .</criteria>
	<gender>All</gender>
	<minimum_age>55 Days</minimum_age>
	<maximum_age>89 Days</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Meningococcal</keyword>
	<keyword>ACWY</keyword>
	<keyword>Conjugate Vaccine</keyword>
	<keyword>Meningitis</keyword>
	<keyword>Infants</keyword>
	<keyword>Persistence</keyword>
</DOC>